U.S. equities extended their AI-fueled winning streak on Wednesday, May 6, with the major indices pushing deeper into record territory as chip stocks, easing oil ($95.63/bbl,-6.49%), and a budding “peace premium” outweighed lingering rate and inflation worries.
Indices and risk tone
The…
US equities extended their record-setting run on Tuesday as mega-cap tech and AI beneficiaries pulled the tape higher again, even as oil backed off recent spikes and macro data painted a picture of solid but not spectacular growth heading into a heavy…
US stocks opened the first full week of May on the back foot, with all three major indices closing lower Monday as investors digested big AI‑software earnings against a still higher‑for‑longer macro and rates backdrop. The tone was risk‑off rather than panicked:…
U.S. equities finished the week ending Friday, May 1, 2026 on a strong note, with the S&P 500 and Nasdaq punching out fresh record highs as mega-cap tech, AI beneficiaries, and a better‑behaved oil tape helped investors look through geopolitical and inflation…
US stocks ripped higher on Thursday, capping April with a powerful relief rally that delivered the strongest monthly performance for equities since 2020, as investors cheered resilient growth data, a calmer Treasury market, and Big Tech earnings that were good enough to…
Markets traded lower Wednesday, April 29, 2026, as investors braced for a critical one-two punch: the Federal Reserve's rate decision and earnings from four of the Magnificent 7 tech giants after the closing bell. The S&P 500 closed at 7,135.95, down 0.04%,…
U.S. stocks saw a split tape early on Tuesday, April 28, 2026, with the tech‑heavy Nasdaq sliding while the Dow rising, but investors sold off at the end as they balanced earnings, rising oil, and higher Treasury yields in front of Wednesday’s…
McDonald’s (MCD) has handled low-carb fads, kale revolutions, and the brief reign of cauliflower rice, but its newest rival comes with a prescription label and a co-pay. GLP-1 weight-loss medicines—from injectables like Eli Lilly’s (LLY) Mounjaro and Zepbound to the next wave…
US stocks extended last week’s relief rally on Monday, with megacap tech doing most of the heavy lifting while value names tried to remember what outperformance felt like. Investors spent the session toggling between AI euphoria, tariff anxiety and a yield curve…
Wall Street closed the week ending Feb. 6, 2026 looking a bit like a trader after a rough options expiry: bruised, but suddenly energetic once the bell rang on Friday. The Dow finally cracked the 50,000 mark in a more-than-1,000‑point sprint, while…
